4-Phenyl-5-[3-(trifluoromethyl)benzenesulfonyl]-1,2,3-thiadiazole

Catalog No. :
ACQZJN974
CAS No. :
338398-39-3
Molecular Formula :
C15H9F3N2O2S2
Molecular Weight :
370.38

IUPAC Name:4-phenyl-5-((3-(trifluoromethyl)phenyl)sulfonyl)-1,2,3-thiadiazole

4-Phenyl-5-[3-(trifluoromethyl)benzenesulfonyl]-1,2,3-thiadiazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Phenyl-5-[3-(trifluoromethyl)benzenesulfonyl]-1,2,3-thiadiazole
IUPAC Name4-phenyl-5-((3-(trifluoromethyl)phenyl)sulfonyl)-1,2,3-thiadiazole
MDL No.MFCD00172444
Molecular FormulaC15H9F3N2O2S2
Molecular Weight370.38
SMILESO=S(C1=C(C2=CC=CC=C2)N=NS1)(C3=CC=CC(C(F)(F)F)=C3)=O
InChI KeyGTMUXUDCPDTHGW-UHFFFAOYSA-N
Synonym4-PHENYL-1,2,3-THIADIAZOL-5-YL 3-(TRIFLUOROMETHYL)PHENYL SULFONE;4-PHENYL-5-([3-(TRIFLUOROMETHYL)PHENYL]SULFONYL)-1,2,3-THIADIAZOLE;4-phenyl-5-[3-(trifluoromethyl)benzenesulfonyl]-1,2,3-thiadiazole;1,2,3-Thiadiazole, 4-phenyl-5-[[3-(trifluoromethyl)phenyl]sulfonyl]-
CAS No.338398-39-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACQZJN974 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQZJN974 route product structure diagram
    ACQZJN974338398-39-3
Inquiry

2. ACQZJN974 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQZJN974 route product structure diagram
    ACQZJN974338398-39-3
Inquiry

Comments (0)